Department of Medicine I, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt am Main, 60590, Germany.
Servizio di Endocrinologia e Diabetologia, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Rev Endocr Metab Disord. 2024 Feb;25(1):161-173. doi: 10.1007/s11154-023-09841-1. Epub 2023 Nov 10.
Ultrasound (US) of the thyroid has been used as a diagnostic tool since the late 1960s. US is the most important imaging tool for diagnosing thyroid disease. In the majority of cases a correct diagnosis can already be made in synopsis of the sonographic together with clinical findings and basal thyroid hormone parameters. However, the characterization of thyroid nodules by US remains challenging. The introduction of Thyroid Imaging Reporting and Data Systems (TIRADSs) has improved diagnostic accuracy of thyroid cancer significantly. Newer techniques such as elastography, superb microvascular imaging (SMI), contrast enhanced ultrasound (CEUS) and multiparametric ultrasound (MPUS) expand diagnostic options and tools further. In addition, the use of artificial intelligence (AI) is a promising tool to improve and simplify diagnostics of thyroid nodules and there is evidence that AI can exceed the performance of humans. Combining different US techniques with the introduction of new software, the use of AI, FNB as well as molecular markers might pave the way for a completely new area of diagnostic accuracy in thyroid disease. Finally, interventional ultrasound using US-guided thermal ablation (TA) procedures are increasingly proposed as therapy options for benign as well as malignant thyroid diseases.
自 20 世纪 60 年代末以来,超声(US)已被用于甲状腺的诊断。US 是诊断甲状腺疾病的最重要的成像工具。在大多数情况下,通过超声与临床发现和基础甲状腺激素参数的综合分析,就可以做出正确的诊断。然而,US 对甲状腺结节的特征描述仍然具有挑战性。甲状腺成像报告和数据系统(TIRADS)的引入显著提高了甲状腺癌的诊断准确性。新的技术,如弹性成像、超微血流成像(SMI)、对比增强超声(CEUS)和多参数超声(MPUS)进一步扩展了诊断的选择和工具。此外,人工智能(AI)的应用是改善和简化甲状腺结节诊断的有前途的工具,有证据表明 AI 可以超过人类的表现。结合不同的超声技术,引入新的软件、AI 的使用、细针穿刺活检(FNB)以及分子标志物,可能为甲状腺疾病的诊断准确性开辟一个全新的领域。最后,超声引导热消融(TA)等介入性超声治疗技术正越来越多地被提议用于治疗良性和恶性甲状腺疾病。
Rev Endocr Metab Disord. 2024-2
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019-6-28
BMC Med Imaging. 2017-12-28
J Med Ultrason (2001). 2020-4
Quant Imaging Med Surg. 2025-9-1
Front Endocrinol (Lausanne). 2025-6-4
NPJ Digit Med. 2025-5-3
Bioengineering (Basel). 2025-3-13
Eur J Radiol Open. 2024-10-31
J Clin Endocrinol Metab. 2023-12-21
Clin Endocrinol (Oxf). 2023-3
Cureus. 2021-9-24
Eur J Endocrinol. 2021-6-28